Facebook Twitter Youtube Vk Rss
Facebook Twitter Youtube Vk Rss
  Trending
T12 Halt and More- 24/7 Market News Snapshot 1 Dec 2023 December 1, 2023
Exclusive Option Agreement May Catch Some Shorts December 1, 2023
Nex Blast Off December 1, 2023
Ampio with the Strong Finish- 24/7 Market News Daily Wrap 30 Nov 2023 November 30, 2023
24/7 Market News Lunch Break 30 Nov 2023 November 30, 2023
Next
Prev

AstraZeneca weighing bid for Mereo BioPharma: Report

  • Jun 17, 2022 at 3:44 AM

Today 3:44 AM ET (MarketWatch)

AstraZeneca (AZN.LN) is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma (MREO), The Times reported without attribution. AstraZeneca already is a partner of Mereo, and the report said it may face competition from another of the cancer and rare disease specialist’s partners, which include Novartis (NOVN.EB), OncXerna and Ultragenyx (RARE).

https://www.marketwatch.com/story/astrazeneca-weighing-bid-for-mereo-biopharma-report-2022-06-17

RelatedNews

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Follow Us

Facebook-f Twitter Youtube

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.